Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Nutritional status at diagnosis and its relationship with survival and relapse in Mexican children with acute lymphoblastic leukemia: a retrospective study.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
- بيانات النشر:
Original Publication: London : BioMed Central, [2001-
- الموضوع:
- نبذة مختصرة :
Competing Interests: Declarations. Ethics approval and consent to participate: The study was evaluated and approved by the Research and Ethics Committee of the Civil Hospital of Guadalajara "Dr. Juan I. Menchaca" (Comité de ética en investigación del Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" / CONBIOETICA-14-CEI-008-20161212) with the register number 00021. The requirement for informed consent was waived due to the retrospective nature of the study and the use of anonymized data. The study was also registered and approved by the Jalisco State Health Secretary (register number: 0410/20HCJIM/2020). The investigators complied with applicable requirements of the declaration of Helsinki [39]. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Background & Aims: Childhood acute lymphoblastic leukemia (ALL) is a malignancy with varying survival rates across countries with low, middle, and high income. The assessment of nutritional status (NS) using anthropometric indicators has been explored for its potential relationship on treatment outcomes. This study analyzed a 3-year retrospective cohort of Mexican pediatric patients with ALL, exploring the association between NS at diagnosis and relapse/mortality.
Methods: Retrospective observational study. Medical records from 252 pediatric patients with ALL were included; anthropometric indicators (Z-scores) of body weight, height, mid-upper arm circumference (MUAC), and triceps and subscapular skinfolds (TSF and SSF, respectively) measurements were used to assess NS. The relapse/mortality data were collected from medical records. Kaplan-Meier (KM) functions and Cox regression models were performed to evaluate the effect of indicators on survival, relapse, and event (death or disease relapse).
Results: Patients with malnutrition showed a significantly lower survival rate according to their BMI (76% vs 63%, p = 0.049), while relapses were higher in the group with TSF < -2 SD (41% vs 12%, p = 0.007). Patients with stunting and TSF < -2 SD showed a higher risk of mortality (HR:6.214, 95%CI: 1.372 to 28.154; HR:2.91, 95%CI: 1.27 to 6.68, respectively), while in patients with higher MUAC Z-score showed a decrease in the mortality risk (HR:0.85, 95%CI:0.73 to 1.00).
Conclusions: The nutritional status assessed by anthropometric measurements was a strong predictor of survival and relapse outcomes 3y post/diagnosis in this cohort of pediatric patients with ALL.
(© 2025. The Author(s).)
- References:
JAMA. 2013 Nov 27;310(20):2191-4. (PMID: 24141714)
Cancer Rep (Hoboken). 2023 Apr;6(4):e1784. (PMID: 36700480)
Eur J Cancer. 2012 Jan;48(2):243-52. (PMID: 21737253)
Ann Oncol. 2015 Mar;26(3):589-97. (PMID: 25527416)
J Clin Oncol. 2022 Aug 1;40(22):2491-2507. (PMID: 35576506)
Clin Nutr ESPEN. 2021 Jun;43:436-441. (PMID: 34024552)
Bol Med Hosp Infant Mex. 2017 Jan - Feb;74(1):13-26. (PMID: 29364809)
Sci Rep. 2023 Aug 21;13(1):13590. (PMID: 37604919)
Salud Publica Mex. 2023 Jun 13;65:s211-s217. (PMID: 38060958)
Stat Med. 1992 Jul;11(10):1305-19. (PMID: 1518992)
J Pediatr Hematol Oncol. 2013 Aug;35(6):437-43. (PMID: 23211695)
Adv Nutr. 2011 Mar;2(2):67-77. (PMID: 22332035)
Children (Basel). 2020 Nov 07;7(11):. (PMID: 33171756)
Pediatr Blood Cancer. 2019 Jun;66(6):e27647. (PMID: 30729661)
Pediatr Blood Cancer. 2017 Jun;64(6):. (PMID: 27905680)
Am J Clin Nutr. 2016 Mar;103(3):808-17. (PMID: 26864366)
Health Policy Plan. 2020 Apr 1;35(3):291-301. (PMID: 31872242)
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):366-380. (PMID: 31916411)
Clin Nutr. 2015 Feb;34(1):66-73. (PMID: 24508424)
Salud Publica Mex. 2024 Apr 29;66(3, may-jun):304-306. (PMID: 39977050)
J Pediatr Hematol Oncol. 2016 Oct;38(7):e217-22. (PMID: 27164536)
J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):502-5. (PMID: 11132216)
Lancet Haematol. 2017 May;4(5):e202-e217. (PMID: 28411119)
Nutr Hosp. 2015 Dec 01;32(6):2862-73. (PMID: 26667745)
Int J Ayurveda Res. 2010 Oct;1(4):274-8. (PMID: 21455458)
J Pediatr. 2017 Nov;190:56-62. (PMID: 29144272)
Haematologica. 2015 Jan;100(1):62-9. (PMID: 25304613)
Medicina (Kaunas). 2023 May 24;59(6):. (PMID: 37374212)
Pediatr Blood Cancer. 2021 Jan;68(1):e28752. (PMID: 33034161)
Lancet Oncol. 2013 Mar;14(3):e95-e103. (PMID: 23434338)
Am J Clin Nutr. 2015 Oct;102(4):891-6. (PMID: 26269368)
Health Syst Reform. 2021 Jan 1;7(1):e1914897. (PMID: 34125000)
Nutrition. 2003 Jul-Aug;19(7-8):597-604. (PMID: 12831945)
JCO Glob Oncol. 2023 Jun;9:e2200288. (PMID: 37290024)
Am J Clin Nutr. 2017 Jan;105(1):111-120. (PMID: 27806975)
PLoS One. 2022 Jun 13;17(6):e0269706. (PMID: 35696384)
Pediatr Blood Cancer. 2020 Jun;67 Suppl 3:e28211. (PMID: 32096326)
Am J Clin Nutr. 2010 Jul;92(1):55-60. (PMID: 20484453)
Indian J Cancer. 2015 Apr-Jun;52(2):210-5. (PMID: 26853408)
Oncologist. 2010;15(5):523-30. (PMID: 20395552)
J Clin Oncol. 2020 Oct 10;38(29):3418-3429. (PMID: 32706634)
Diagnostics (Basel). 2022 Sep 28;12(10):. (PMID: 36292046)
Support Care Cancer. 2015 Jan;23(1):143-50. (PMID: 25011521)
Pediatr Blood Cancer. 2020 Jun;67 Suppl 3:e28207. (PMID: 32083372)
J Pediatr Oncol Nurs. 2021 Sep-Oct;38(5):313-321. (PMID: 33960867)
Ecancermedicalscience. 2021 Dec 02;15:1327. (PMID: 35211196)
Rev Paul Pediatr. 2021;39:e2019209. (PMID: 32756757)
Children (Basel). 2019 Aug 16;6(8):. (PMID: 31426332)
Pediatr Blood Cancer. 2020 Jun;67 Suppl 3:e28117. (PMID: 32134218)
Pediatr Endocrinol Diabetes Metab. 2017;23(2):77-82. (PMID: 29073290)
Front Pediatr. 2023 Mar 06;11:1081139. (PMID: 36950173)
Blood Cancer J. 2017 Feb 17;7(2):e531. (PMID: 28212374)
Am J Clin Nutr. 2006 Jan;83(1):70-4. (PMID: 16400052)
Endocrinol Nutr. 2013 Feb;60(2):69-75. (PMID: 22704270)
Hematol Rep. 2021 Mar 05;13(1):8847. (PMID: 33747412)
Tumori. 2023 Feb;109(1):19-27. (PMID: 35722985)
Salud Publica Mex. 2022 Feb 25;64(1):26-34. (PMID: 35438901)
Nutr Clin Pract. 2015 Feb;30(1):147-61. (PMID: 25422273)
Nutr Cancer. 2021;73(1):83-88. (PMID: 32188289)
Pediatr Blood Cancer. 2016 Aug;63(8):1339-48. (PMID: 27082376)
Nutr Res Pract. 2019 Jun;13(3):214-221. (PMID: 31214289)
Adv Nutr. 2020 Mar 1;11(2):216-223. (PMID: 31529044)
Eur J Haematol. 2020 Dec;105(6):797-807. (PMID: 32909636)
Clin Nutr. 2017 Feb;36(1):11-48. (PMID: 27637832)
Hematol Transfus Cell Ther. 2021 Oct-Dec;43(4):389-395. (PMID: 32631810)
Pediatr Blood Cancer. 2020 Jun;67 Suppl 3:e28213. (PMID: 32096351)
Int J Equity Health. 2019 Mar 4;18(1):40. (PMID: 30832668)
J Egypt Natl Canc Inst. 2022 Jun 13;34(1):25. (PMID: 35696003)
Blood Cancer J. 2017 Jun 30;7(6):e577. (PMID: 28665419)
Lancet Child Adolesc Health. 2020 Jun;4(6):465-475. (PMID: 32061318)
Nutrients. 2023 Jan 30;15(3):. (PMID: 36771416)
Front Biosci (Elite Ed). 2022 Feb 8;14(1):4. (PMID: 35320908)
J Pediatr Hematol Oncol. 2019 Jul;41(5):e308-e321. (PMID: 30475301)
Nutrition. 2007 Oct;23(10):739-44. (PMID: 17716869)
Nutr Clin Pract. 2023 Oct;38(5):1133-1141. (PMID: 37461825)
Leukemia. 2021 Apr;35(4):1001-1011. (PMID: 32820270)
Oncologist. 2016 Nov;21(11):1396-1409. (PMID: 27412391)
JCO Glob Oncol. 2020 Feb;6:242-259. (PMID: 32073908)
- Grant Information:
23649 International Atomic Energy Agency
- Contributed Indexing:
Keywords: ALL, Acute lymphoblastic leukemia; BMI, body mass index; Childhood ALL; Nutritional status; Survival rate
- الموضوع:
Date Created: 20250221 Date Completed: 20250222 Latest Revision: 20250516
- الموضوع:
20250519
- الرقم المعرف:
PMC11846316
- الرقم المعرف:
10.1186/s12885-025-13729-5
- الرقم المعرف:
39984931
No Comments.